- call +1-201-465-4211
- email sales@mrinsights.biz
Automatic Injector is used to inject radiopharmaceuticals into patients to ensure the safety and dose accuracy.
Scope of the Report:
The worldwide market for Radiopharmaceutical Injector is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new research study.
This report focuses on the Radiopharmaceutical Injector in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bright Technologies
Comecer
Lemer Pax
Sumitomo Heavy Industries
Tema Sinergie
Raditec Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Automatic Injector
Manual Injector
Market Segment by Applications, can be divided into
PET Radioactive Drugs
SPECT Radioactive Drugs
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Radiopharmaceutical Injector product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Radiopharmaceutical Injector, with price, sales, revenue and global market share of Radiopharmaceutical Injector in 2017 and 2018.
Chapter 3, the Radiopharmaceutical Injector competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Radiopharmaceutical Injector breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Radiopharmaceutical Injector market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Radiopharmaceutical Injector sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Radiopharmaceutical Injector Introduction
1.2 Market Analysis by Type
1.2.1 Automatic Injector
1.2.2 Manual Injector
1.3 Market Analysis by Applications
1.3.1 PET Radioactive Drugs
1.3.2 SPECT Radioactive Drugs
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bright Technologies
2.1.1 Business Overview
2.1.2 Radiopharmaceutical Injector Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bright Technologies Radiopharmaceutical Injector Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Comecer
2.2.1 Business Overview
2.2.2 Radiopharmaceutical Injector Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Comecer Radiopharmaceutical Injector Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Lemer Pax
2.3.1 Business Overview
2.3.2 Radiopharmaceutical Injector Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Lemer Pax Radiopharmaceutical Injector Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sumitomo Heavy Industries
2.4.1 Business Overview
2.4.2 Radiopharmaceutical Injector Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Tema Sinergie
2.5.1 Business Overview
2.5.2 Radiopharmaceutical Injector Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Tema Sinergie Radiopharmaceutical Injector Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Raditec Medical
2.6.1 Business Overview
2.6.2 Radiopharmaceutical Injector Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Raditec Medical Radiopharmaceutical Injector Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Radiopharmaceutical Injector Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Radiopharmaceutical Injector Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Radiopharmaceutical Injector Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Radiopharmaceutical Injector Manufacturer Market Share in 2018
3.3.2 Top 6 Radiopharmaceutical Injector Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Radiopharmaceutical Injector Market Analysis by Regions
4.1 Global Radiopharmaceutical Injector Sales, Revenue and Market Share by Regions
4.1.1 Global Radiopharmaceutical Injector Sales and Market Share by Regions (2014-2019)
4.1.2 Global Radiopharmaceutical Injector Revenue and Market Share by Regions (2014-2019)
4.2 North America Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
4.3 Europe Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
4.5 South America Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
5 North America Radiopharmaceutical Injector by Country
5.1 North America Radiopharmaceutical Injector Sales, Revenue and Market Share by Country
5.1.1 North America Radiopharmaceutical Injector Sales and Market Share by Country (2014-2019)
5.1.2 North America Radiopharmaceutical Injector Revenue and Market Share by Country (2014-2019)
5.2 United States Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
5.3 Canada Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
5.4 Mexico Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
6 Europe Radiopharmaceutical Injector by Country
6.1 Europe Radiopharmaceutical Injector Sales, Revenue and Market Share by Country
6.1.1 Europe Radiopharmaceutical Injector Sales and Market Share by Country (2014-2019)
6.1.2 Europe Radiopharmaceutical Injector Revenue and Market Share by Country (2014-2019)
6.2 Germany Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
6.3 UK Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
6.4 France Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
6.5 Russia Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
6.6 Italy Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
7 Asia-Pacific Radiopharmaceutical Injector by Country
7.1 Asia-Pacific Radiopharmaceutical Injector Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Radiopharmaceutical Injector Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Radiopharmaceutical Injector Revenue and Market Share by Country (2014-2019)
7.2 China Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
7.3 Japan Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
7.4 Korea Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
7.5 India Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
8 South America Radiopharmaceutical Injector by Country
8.1 South America Radiopharmaceutical Injector Sales, Revenue and Market Share by Country
8.1.1 South America Radiopharmaceutical Injector Sales and Market Share by Country (2014-2019)
8.1.2 South America Radiopharmaceutical Injector Revenue and Market Share by Country (2014-2019)
8.2 Brazil Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
8.3 Argentina Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
8.4 Colombia Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
9 Middle East and Africa Radiopharmaceutical Injector by Countries
9.1 Middle East and Africa Radiopharmaceutical Injector Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Radiopharmaceutical Injector Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Radiopharmaceutical Injector Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
9.3 Turkey Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
9.4 Egypt Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
9.5 Nigeria Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
9.6 South Africa Radiopharmaceutical Injector Sales and Growth Rate (2014-2019)
10 Global Radiopharmaceutical Injector Market Segment by Type
10.1 Global Radiopharmaceutical Injector Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Radiopharmaceutical Injector Sales and Market Share by Type (2014-2019)
10.1.2 Global Radiopharmaceutical Injector Revenue and Market Share by Type (2014-2019)
10.2 Automatic Injector Sales Growth and Price
10.2.1 Global Automatic Injector Sales Growth (2014-2019)
10.2.2 Global Automatic Injector Price (2014-2019)
10.3 Manual Injector Sales Growth and Price
10.3.1 Global Manual Injector Sales Growth (2014-2019)
10.3.2 Global Manual Injector Price (2014-2019)
11 Global Radiopharmaceutical Injector Market Segment by Application
11.1 Global Radiopharmaceutical Injector Sales Market Share by Application (2014-2019)
11.2 PET Radioactive Drugs Sales Growth (2014-2019)
11.3 SPECT Radioactive Drugs Sales Growth (2014-2019)
12 Radiopharmaceutical Injector Market Forecast (2019-2024)
12.1 Global Radiopharmaceutical Injector Sales, Revenue and Growth Rate (2019-2024)
12.2 Radiopharmaceutical Injector Market Forecast by Regions (2019-2024)
12.2.1 North America Radiopharmaceutical Injector Market Forecast (2019-2024)
12.2.2 Europe Radiopharmaceutical Injector Market Forecast (2019-2024)
12.2.3 Asia-Pacific Radiopharmaceutical Injector Market Forecast (2019-2024)
12.2.4 South America Radiopharmaceutical Injector Market Forecast (2019-2024)
12.2.5 Middle East and Africa Radiopharmaceutical Injector Market Forecast (2019-2024)
12.3 Radiopharmaceutical Injector Market Forecast by Type (2019-2024)
12.3.1 Global Radiopharmaceutical Injector Sales Forecast by Type (2019-2024)
12.3.2 Global Radiopharmaceutical Injector Market Share Forecast by Type (2019-2024)
12.4 Radiopharmaceutical Injector Market Forecast by Application (2019-2024)
12.4.1 Global Radiopharmaceutical Injector Sales Forecast by Application (2019-2024)
12.4.2 Global Radiopharmaceutical Injector Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Radiopharmaceutical Injector Picture
Table Product Specifications of Radiopharmaceutical Injector
Figure Global Sales Market Share of Radiopharmaceutical Injector by
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
